Arbidol inhibits the activity of influenza A and B viruses, as well as the coronavirus associated with the severe respiratory syndrome.
The active substance stimulates the humoral and cellular immune responses, which helps to increase resistance to viral infections.
It is a fusion inhibitor - Arbidol interacts with the hemagglutinin of the virus, preventing the fusion of the lipid membrane of the virus and cell membranes.
Reduces the frequency of manifestations of complications associated with exposure to viral infections, and also reduces the frequency of manifestations of exacerbations of bacterial diseases with a chronic course.
The drug is not toxic. A negative effect, when taken orally and in the right dosage, is not observed.